Security
Bristol-Myers Squibb Co. · BMY
BMYNYSECommon stockCurrentCIK 14272Updated Oct 30, 2026
BMY price & chart
Loading TradingView…
NYSE:BMY on TradingView ↗About the company
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.
In the news
The Quest to Repair What Multiple Sclerosis Takes Away ↗
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc. News provided by Rowley Law PLLC Mar 11, 2025, 15:31 ET Share this article Share to X Share this article Share to X NEW YORK , March 11, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law v ↗
Seeking Alpha
BioNTech Q3: Bristol Myers Revenue Masks A Narrowing Oncology Bet (Rating Downgrade) ↗
Teva raises 2026 outlook on strength of innovative brands ↗
SCHD Into Midterms: Healthcare A Concern ↗
SEC disclosures
BRISTOL MYERS SQUIBB CO files 8-K: Material Event ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 96,889,000,000Source | 93,670,000,000Source | 87,634,000,000Source | 94,676,000,000Source | 94,646,000,000Source | 86,476,000,000Source | 92,427,000,000Source | 99,031,000,000Source | 90,038,000,000Source | 92,603,000,000Source | 95,159,000,000Source | 96,820,000,000Source |
| Property, Plant and Equipment, NetUSD | 7,349,000,000Source | 6,903,000,000Source | 7,791,000,000Source | 7,373,000,000Source | 6,845,000,000Source | 7,658,000,000Source | 7,213,000,000Source | 6,750,000,000Source | 7,543,000,000Source | 7,136,000,000Source | 6,646,000,000Source | 6,255,000,000Source |
| GoodwillUSD | 21,745,000,000Source | 21,751,000,000Source | 21,740,000,000Source | 21,776,000,000Source | 21,732,000,000Source | 21,740,000,000Source | 21,737,000,000Source | 21,738,000,000Source | 21,754,000,000Source | 21,719,000,000Source | 21,169,000,000Source | 21,149,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 20,465,000,000Source | 26,964,000,000Source | 17,387,000,000Source | 21,378,000,000Source | 29,428,000,000Source | 18,244,000,000Source | 22,486,000,000Source | 32,760,000,000Source | 19,103,000,000Source | 23,307,000,000Source | 27,072,000,000Source | 35,859,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 15,726,000,000Source | 7,890,000,000Source | 8,722,000,000Source | 12,599,000,000Source | 6,293,000,000Source | 9,574,000,000Source | 10,875,000,000Source | 9,330,000,000Source | 10,209,000,000Source | 10,346,000,000Source | 11,464,000,000Source | 9,123,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 9,624,000,000Source | 9,317,000,000Source | 9,077,000,000Source | 9,711,000,000Source | 9,746,000,000Source | 7,946,000,000Source | 9,063,000,000Source | 8,826,000,000Source | 9,592,000,000Source | 9,012,000,000Source | 8,882,000,000Source | 8,151,000,000Source |
| Inventory, NetUSD | 2,758,000,000Source | 3,332,000,000Source | 2,737,000,000Source | 2,737,000,000Source | 3,077,000,000Source | 2,756,000,000Source | 2,666,000,000Source | 2,985,000,000Source | 2,690,000,000Source | 2,557,000,000Source | 2,662,000,000Source | 2,339,000,000Source |
| Assets, CurrentUSD | 35,630,000,000Source | 28,075,000,000Source | 28,579,000,000Source | 33,222,000,000Source | 26,890,000,000Source | 27,208,000,000Source | 30,783,000,000Source | 28,669,000,000Source | 29,390,000,000Source | 29,780,000,000Source | 31,770,000,000Source | 27,273,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,604,000,000Source | 1,348,000,000Source | 1,486,000,000Source | 1,276,000,000Source | 1,316,000,000Source | 1,528,000,000Source | 1,215,000,000Source | 1,436,000,000Source | 1,582,000,000Source | 1,224,000,000Source | 1,390,000,000Source | 1,220,000,000Source |
| Other Assets, NoncurrentUSD | 6,332,000,000Source | 6,044,000,000Source | 6,378,000,000Source | 5,936,000,000Source | 6,071,000,000Source | 6,082,000,000Source | 5,866,000,000Source | 6,024,000,000Source | 6,474,000,000Source | 6,105,000,000Source | 5,370,000,000Source | 4,940,000,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 78,289,000,000Source | 76,470,000,000Source | 65,315,000,000Source | 77,187,000,000Source | 77,577,000,000Source | 66,374,000,000Source | 74,979,000,000Source | 82,483,000,000Source | 71,533,000,000Source | 76,215,000,000Source | 65,674,000,000Source | 65,702,000,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | — | — | — | — | — | — | — | — | — | — | — | 292,000,000Source |
| Additional Paid in CapitalUSD | 46,265,000,000Source | 45,896,000,000Source | 46,504,000,000Source | 46,134,000,000Source | 45,766,000,000Source | 46,374,000,000Source | 46,011,000,000Source | 45,655,000,000Source | 46,387,000,000Source | 46,024,000,000Source | 45,684,000,000Source | 45,165,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 17,093,000,000Source | 16,097,000,000Source | 20,316,000,000Source | 16,154,000,000Source | 16,103,000,000Source | 18,287,000,000Source | 16,106,000,000Source | 15,640,000,000Source | 16,896,000,000Source | 14,912,000,000Source | 28,766,000,000Source | 25,503,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,513,000,000Source | -1,468,000,000Source | -1,290,000,000Source | -1,554,000,000Source | -1,456,000,000Source | -1,370,000,000Source | -1,424,000,000Source | -1,400,000,000Source | -1,524,000,000Source | -1,238,000,000Source | -1,546,000,000Source | -1,281,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 18,552,000,000Source | 17,142,000,000Source | 22,319,000,000Source | 17,435,000,000Source | 17,015,000,000Source | 20,068,000,000Source | 17,389,000,000Source | 16,490,000,000Source | 18,473,000,000Source | 16,335,000,000Source | 29,430,000,000Source | 31,061,000,000Source |
| Liabilities and EquityUSD | 96,889,000,000Source | 93,670,000,000Source | 87,634,000,000Source | 94,676,000,000Source | 94,646,000,000Source | 86,476,000,000Source | 92,427,000,000Source | 99,031,000,000Source | 90,038,000,000Source | 92,603,000,000Source | 95,159,000,000Source | 96,820,000,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 28,136,000,000Source | 22,638,000,000Source | 18,659,000,000Source | 27,528,000,000Source | 23,265,000,000Source | 19,158,000,000Source | 24,070,000,000Source | 25,822,000,000Source | 23,417,000,000Source | 23,774,000,000Source | 22,262,000,000Source | 21,890,000,000Source |
| Operating Lease, Liability, CurrentUSD | 214,000,000Source | 165,000,000Source | 207,000,000Source | 194,000,000Source | 177,000,000Source | 199,000,000Source | 172,000,000Source | 169,000,000Source | 202,000,000Source | 181,000,000Source | 162,000,000Source | 136,000,000Source |
| Accounts Payable, CurrentUSD | 4,288,000,000Source | 3,469,000,000Source | 4,158,000,000Source | 5,427,000,000Source | 3,751,000,000Source | 4,234,000,000Source | 4,002,000,000Source | 3,539,000,000Source | 3,575,000,000Source | 3,602,000,000Source | 3,259,000,000Source | 3,040,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,849,000,000Source | 1,483,000,000Source | 1,726,000,000Source | 1,550,000,000Source | 1,438,000,000Source | 1,770,000,000Source | 1,356,000,000Source | 1,563,000,000Source | 1,826,000,000Source | 1,370,000,000Source | 1,530,000,000Source | 1,261,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 225,000,000Source | 430,000,000Source | 222,000,000Source | 247,000,000Source | 461,000,000Source | 211,000,000Source | 276,000,000Source | 442,000,000Source | 222,000,000Source | 369,000,000Source | 338,000,000Source | 2,166,000,000Source |
| Other Liabilities, NoncurrentUSD | 5,459,000,000Source | 4,728,000,000Source | 4,341,000,000Source | 4,942,000,000Source | 4,993,000,000Source | 4,853,000,000Source | 4,477,000,000Source | 6,732,000,000Source | 5,043,000,000Source | 4,469,000,000Source | 6,421,000,000Source | 6,590,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 48,000,000Source | 58,000,000Source | 0Source | 54,000,000Source | 54,000,000Source | 34,000,000Source | 59,000,000Source | 58,000,000Source | 33,000,000Source | 53,000,000Source | 55,000,000Source | 57,000,000Source |
| Additional Financial Items | ||||||||||||
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | 3,000,000Source | 5,000,000Source | -1,000,000Source | 3,000,000Source | 0Source | 0Source | 2,000,000Source | 0Source | 3,000,000Source | 2,000,000Source | 2,000,000Source | 0Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | 626,000,000Source | 689,000,000Source | 559,000,000Source | 645,000,000Source | 789,000,000Source | 560,000,000Source | 647,000,000Source | 725,000,000Source | 566,000,000Source | 648,000,000Source | 738,000,000Source | 623,000,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 822,000,000Source |
| Dividends Payable, CurrentUSD | 1,262,000,000Source | 1,217,000,000Source | 1,288,000,000Source | 1,262,000,000Source | 1,217,000,000Source | 1,286,000,000Source | 1,262,000,000Source | 1,216,000,000Source | 1,283,000,000Source | 1,258,000,000Source | 1,213,000,000Source | 1,196,000,000Source |
| Long-term Debt, Excluding Current Maturities | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | 4,248,000,000Source | 873,000,000Source | 768,000,000Source | 4,475,000,000Source | 3,092,000,000Source | 1,988,000,000Source | 3,349,000,000Source | 2,873,000,000Source | 1,977,000,000Source | 1,828,000,000Source | 2,873,000,000Source | 3,897,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 44,469,000,000Source | 48,674,000,000Source | 42,093,000,000Source | 44,470,000,000Source | 48,858,000,000Source | 42,152,000,000Source | 46,157,000,000Source | 49,487,000,000Source | 42,850,000,000Source | 47,603,000,000Source | 36,653,000,000Source | 35,056,000,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 2,195,000,000Source | 1,215,000,000Source | 3,316,000,000Source | 1,313,000,000Source | 2,678,000,000Source | 2,462,000,000Source | 7,055,000,000Source | -8,933,000,000Source | 8,040,000,000Source | 6,345,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 594,000,000Source | 1,012,000,000Source | 4,011,000,000Source | 9,600,000,000Source | 9,760,000,000Source | 10,276,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 146,000,000Source | 144,000,000Source | 553,000,000Source | 507,000,000Source | 518,000,000Source | 457,000,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -14,000,000Source | 169,000,000Source | 184,000,000Source | 486,000,000Source | 751,000,000Source | 69,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 409,000,000Source | -85,000,000Source | -2,000,000Source | 184,000,000Source | 198,000,000Source | 109,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 161,000,000Source | 223,000,000Source | -965,000,000Source | -2,089,000,000Source | -3,288,000,000Source | -2,738,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 1,104,000,000Source | 1,954,000,000Source | 14,156,000,000Source | 15,190,000,000Source | 13,860,000,000Source | 13,066,000,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 65,000,000Source | 78,000,000Source | 3,944,000,000Source | 21,821,000,000Source | 1,169,000,000Source | 4,286,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -131,000,000Source | -499,000,000Source | -4,132,000,000Source | -21,352,000,000Source | -2,295,000,000Source | -1,062,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 347,000,000Source | 260,000,000Source | 1,311,000,000Source | 1,248,000,000Source | 1,209,000,000Source | 1,118,000,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 5,155,000,000Source | 8,001,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,560,000,000Source | -993,000,000Source | -10,348,000,000Source | 5,127,000,000Source | -9,416,000,000Source | -16,962,000,000Source |
| Dividends paid | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 27,000,000Source | 984,000,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 500,000,000Source | 0Source | 10,940,000,000Source | 2,873,000,000Source | 3,879,000,000Source | 11,431,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -635,000,000Source | 528,000,000Source | -129,000,000Source | -1,172,000,000Source | 2,194,000,000Source | -4,991,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 15,726,000,000Source | 7,893,000,000Source | 8,722,000,000Source | 12,611,000,000Source | 9,583,000,000Source | 10,875,000,000Source | 10,218,000,000Source | 10,347,000,000Source | 11,519,000,000Source | 9,325,000,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 473,000,000Source | 624,000,000Source | 2,100,000,000Source | 1,800,000,000Source | 1,200,000,000Source | 1,400,000,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 239,000,000Source | 235,000,000Source | 3,264,000,000Source | 3,900,000,000Source | 4,300,000,000Source | 5,400,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -48,000,000Source | 66,000,000Source | 195,000,000Source | -137,000,000Source | 45,000,000Source | -33,000,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 139,000,000Source | 129,000,000Source | 135,000,000Source | 138,000,000Source | 146,000,000Source | 144,000,000Source | 553,000,000Source | 507,000,000Source | 518,000,000Source | 457,000,000Source |
| Amortization of Intangible AssetsUSD | — | — | 867,000,000Source | 2,400,000,000Source | 471,000,000Source | 864,000,000Source | 472,000,000Source | 863,000,000Source | 3,500,000,000Source | 9,000,000,000Source | 9,200,000,000Source | 9,700,000,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | 100,000,000Source | — | — | — | — | — | -119,000,000Source | — | — |
| DepreciationUSD | — | — | 159,000,000Source | 166,000,000Source | 139,000,000Source | 165,000,000Source | 139,000,000Source | 165,000,000Source | 621,000,000Source | 651,000,000Source | 611,000,000Source | 587,000,000Source |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on DisposalUSD | — | — | -8,000,000Source | -5,000,000Source | 138,000,000Source | -1,000,000Source | 24,000,000Source | 9,000,000Source | -1,000,000Source | -15,000,000Source | 0Source | 211,000,000Source |
| Dividends Payable, CurrentUSD | — | — | 1,262,000,000Source | 1,217,000,000Source | 1,288,000,000Source | 1,262,000,000Source | 1,286,000,000Source | 1,262,000,000Source | 1,283,000,000Source | 1,258,000,000Source | 1,213,000,000Source | 1,196,000,000Source |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | — | — | — | — | 134,000,000Source | -78,000,000Source | 280,000,000Source | 16,000,000Source | -160,000,000Source | -801,000,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | 0Source | 3,000,000Source | 1,000,000Source | -2,000,000Source | 6,000,000Source | -4,000,000Source | 4,000,000Source | -32,000,000Source | 3,000,000Source | 17,000,000Source |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | 166,000,000Source | 33,000,000Source | 50,000,000Source | 4,000,000Source | 35,000,000Source | -5,000,000Source | 291,000,000Source | -41,000,000Source | -117,000,000Source | -762,000,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | 190,000,000Source | 12,000,000Source | 114,000,000Source | -22,000,000Source | 134,000,000Source | -78,000,000Source | 280,000,000Source | 16,000,000Source | -160,000,000Source | -801,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -165,000,000Source | 0Source | -5,000,000Source | -1,000,000Source | -4,000,000Source | -257,000,000Source | -434,000,000Source | -84,000,000Source | 390,000,000Source | -178,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | -356,000,000Source | 0Source | 0Source | -266,000,000Source |
| GoodwillUSD | — | — | 21,745,000,000Source | 21,751,000,000Source | 21,740,000,000Source | 21,776,000,000Source | 21,740,000,000Source | 21,737,000,000Source | 21,754,000,000Source | 21,719,000,000Source | 21,169,000,000Source | 21,149,000,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 47,000,000Source | — | — | — | — | 949,000,000Source | 2,900,000,000Source | 136,000,000Source | 101,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | -6,000,000Source | -23,000,000Source | 60,000,000Source | -37,000,000Source | 25,000,000Source | -9,000,000Source | 47,000,000Source | 44,000,000Source | -38,000,000Source | -108,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 919,000,000Source | 461,000,000Source | 770,000,000Source | 460,000,000Source | 561,000,000Source | 509,000,000Source | 2,272,000,000Source | 554,000,000Source | 400,000,000Source | 1,368,000,000Source |
| InterestExpenseNonoperatingUSD | — | — | 480,000,000Source | 505,000,000Source | 407,000,000Source | 485,000,000Source | 411,000,000Source | 494,000,000Source | 1,891,000,000Source | 1,947,000,000Source | — | — |
| Investment Income, InterestUSD | — | — | 161,000,000Source | 94,000,000Source | 101,000,000Source | 139,000,000Source | 104,000,000Source | 138,000,000Source | 586,000,000Source | 478,000,000Source | 449,000,000Source | 171,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 2,201,000,000Source | 1,211,000,000Source | 3,317,000,000Source | 1,310,000,000Source | 2,677,000,000Source | 2,456,000,000Source | 7,054,000,000Source | -8,948,000,000Source | 8,025,000,000Source | 6,327,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 18,000,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 85,000,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | 108,000,000Source | -234,000,000Source | 61,000,000Source | -494,000,000Source | -32,000,000Source | -339,000,000Source | -674,000,000Source | -893,000,000Source | 1,158,000,000Source | -576,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | 0Source | 5,740,000,000Source | 12,883,000,000Source | 4,455,000,000Source | 5,926,000,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | — | — | 232,000,000Source | 263,000,000Source | -32,000,000Source | 279,000,000Source | 1,000,000Source | 190,000,000Source | 926,000,000Source | 1,131,000,000Source | 777,000,000Source | 520,000,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | 166,000,000Source | 30,000,000Source | 49,000,000Source | 6,000,000Source | 29,000,000Source | -1,000,000Source | 287,000,000Source | -9,000,000Source | -120,000,000Source | -779,000,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 12,222,000,000Source | 11,892,000,000Source | 12,973,000,000Source | 12,269,000,000Source | 11,489,000,000Source | 11,201,000,000Source | 48,194,000,000Source | 48,300,000,000Source | 45,006,000,000Source | 46,159,000,000Source |
| Cost of RevenueUSD | — | — | 3,435,000,000Source | 2,957,000,000Source | 3,726,000,000Source | 3,372,000,000Source | 3,421,000,000Source | 3,033,000,000Source | 13,936,000,000Source | 13,968,000,000Source | 10,693,000,000Source | 10,137,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 1,789,000,000Source | 1,983,000,000Source | 1,826,000,000Source | 1,713,000,000Source | 1,617,000,000Source | 1,584,000,000Source | 7,267,000,000Source | 8,414,000,000Source | 7,772,000,000Source | 7,814,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 108,000,000Source | -234,000,000Source | 61,000,000Source | -494,000,000Source | -32,000,000Source | -339,000,000Source | -674,000,000Source | -893,000,000Source | 1,158,000,000Source | -576,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 3,114,000,000Source | 1,676,000,000Source | 4,086,000,000Source | 1,773,000,000Source | 3,240,000,000Source | 2,971,000,000Source | 9,328,000,000Source | -8,379,000,000Source | 8,440,000,000Source | 7,713,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 919,000,000Source | 461,000,000Source | 770,000,000Source | 460,000,000Source | 561,000,000Source | 509,000,000Source | 2,272,000,000Source | 554,000,000Source | 400,000,000Source | 1,368,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 18,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 2,201,000,000Source | 1,211,000,000Source | 3,317,000,000Source | 1,310,000,000Source | 2,677,000,000Source | 2,456,000,000Source | 7,054,000,000Source | -8,948,000,000Source | 8,025,000,000Source | 6,327,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 1.08Source | 0.6Source | 1.62Source | 0.64Source | 1.31Source | 1.21Source | 3.47Source | -4.41Source | 3.88Source | 2.97Source |
| Earnings Per Share, DilutedUSD per share | — | — | 1.08Source | 0.6Source | 1.62Source | 0.64Source | 1.31Source | 1.2Source | 3.46Source | -4.41Source | 3.86Source | 2.95Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 2,036,000,000Source | 2,028,000,000Source | 2,042,000,000Source | 2,035,000,000Source | 2,038,000,000Source | 2,031,000,000Source | 2,034,000,000Source | 2,027,000,000Source | 2,069,000,000Source | 2,130,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 2,039,000,000Source | 2,031,000,000Source | 2,048,000,000Source | 2,038,000,000Source | 2,047,000,000Source | 2,040,000,000Source | 2,039,000,000Source | 2,027,000,000Source | 2,078,000,000Source | 2,146,000,000Source |
| Interest Expense (non-operating)USD | — | — | 480,000,000Source | 505,000,000Source | 407,000,000Source | 485,000,000Source | 411,000,000Source | 494,000,000Source | 1,891,000,000Source | 1,947,000,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 867,000,000Source | 2,400,000,000Source | 471,000,000Source | 864,000,000Source | 472,000,000Source | 863,000,000Source | 3,500,000,000Source | 9,000,000,000Source | 9,200,000,000Source | 9,700,000,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.62Source | 0.6Source | 0.63Source | 0.62Source | 0.63Source | 0.62Source | 2.49Source | 2.42Source | 2.31Source | 2.19Source |
| Costs and ExpensesUSD | — | — | 9,108,000,000Source | 10,216,000,000Source | 8,887,000,000Source | 10,496,000,000Source | 8,250,000,000Source | 8,230,000,000Source | 38,866,000,000Source | 56,679,000,000Source | 36,566,000,000Source | 38,446,000,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 3,237,000,000Source | 2,643,000,000Source | 3,688,000,000Source | 4,106,000,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | 100,000,000Source | — | — | — | — | — | -119,000,000Source | — | — |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | 0Source | 3,000,000Source | 1,000,000Source | -2,000,000Source | 6,000,000Source | -4,000,000Source | 4,000,000Source | -32,000,000Source | 3,000,000Source | 17,000,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | 190,000,000Source | 12,000,000Source | 114,000,000Source | -22,000,000Source | 134,000,000Source | -78,000,000Source | 280,000,000Source | 16,000,000Source | -160,000,000Source | -801,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -165,000,000Source | 0Source | -5,000,000Source | -1,000,000Source | -4,000,000Source | -257,000,000Source | -434,000,000Source | -84,000,000Source | 390,000,000Source | -178,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -19,000,000Source | -14,893,000,000Source | 2,624,000,000Source | -140,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | -6,000,000Source | -23,000,000Source | 60,000,000Source | -37,000,000Source | 25,000,000Source | -9,000,000Source | 47,000,000Source | 44,000,000Source | -38,000,000Source | -108,000,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 1,166,000,000Source | 1,232,000,000Source |
| Investment Income, InterestUSD | — | — | 161,000,000Source | 94,000,000Source | 101,000,000Source | 139,000,000Source | 104,000,000Source | 138,000,000Source | 586,000,000Source | 478,000,000Source | 449,000,000Source | 171,000,000Source |
| Marketing and Advertising ExpenseUSD | — | — | — | — | — | — | — | — | 1,300,000,000Source | 1,500,000,000Source | 1,400,000,000Source | 1,300,000,000Source |
| Research and Development ExpenseUSD | — | — | 2,528,000,000Source | 2,374,000,000Source | 2,959,000,000Source | 2,580,000,000Source | 2,649,000,000Source | 2,257,000,000Source | 9,951,000,000Source | 11,159,000,000Source | 9,299,000,000Source | 9,509,000,000Source |
Filing attachments
a2026q3ex991-filing.htm · 8-K · 2026-10-29
Exhibit 99.1 Bristol Myers Squibb Reports Third Quarter Financial Results for 2026 and Raises Full-Year Revenue Outlook Growth Portfolio Performance and Disciplined Execution Drive Strong Financial Results Key Pipeline Milestones Include Regulatory Approvals and Positive Registrational Data Across Multiple Therapeutic Areas • Third quarter revenues increased 7% to $13.1 billion ◦ Growth Portfolio revenues increased 12% to $7.7 billion • GAAP EPS was $1.05 and non-GAAP EPS was $1.35; Both f…
Read attachment ↗a2026q2ex991-filing.htm · 8-K · 2026-07-30
EX-99.1 2 a2026q2ex991-filing.htm PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY DATED JULY 30, 2026 Document Exhibit 99.1 Bristol Myers Squibb Reports Second Quarter Financial Results for 2026 and Raises Full-Year Outlook Strong Performance Underscores Growth Portfolio Momentum and Pipeline Progress • Second quarter revenues increased 6% (+5% Ex-FX) to $13.0 billion ◦ Growth Portfolio revenues increased 15% (+14% Ex-FX) to $7.6 billion • GAAP EPS was $1.62 and non-GAAP EPS was $2.04 •…
Read attachment ↗ef20072737_ex107.htm · S-8 · 2026-05-08
Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Bristol-Myers Squibb Company (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Maximum Aggregate Fee Rate Amount of Registration Fee …
Read attachment ↗a2026q1ex991.htm · 8-K · 2026-04-30
EX-99.1 2 a2026q1ex991.htm PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY DATED APRIL 30, 2026 Document Exhibit 99.1 Bristol Myers Squibb Reports First Quarter Financial Results for 2026 Financial Results Reflect Strong Execution and a Strengthened Foundation with Significant Pipeline Milestones Ahead • First quarter revenues increased 3% (+1% Ex-FX) to $11.5 billion ◦ Growth Portfolio revenues increased 12% (+9% Ex-FX) to $6.2 billion • GAAP EPS was $1.31 and non-GAAP EPS was $1.58; Bo…
Read attachment ↗a2025q4ex991.htm · 8-K · 2026-02-05
Exhibit 99.1 Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025 Financial results reflect disciplined execution and focus on delivering long-term growth • Fourth quarter revenues increased 1% to $12.5 billion; Growth Portfolio revenues increased 16% to $7.4 billion ◦ GAAP EPS was $0.53 and non-GAAP EPS was $1.26; Both figures include net impact of $(0.60) due to the Acquired IPRD charges and licensing income • Full-year revenues were $48.2 billion; Growth P…
Read attachment ↗ef20062582_ex99-1.htm · 8-K · 2026-01-12
EX-99.1 2 ef20062582_ex99-1.htm INVESTOR PRESENTATION OF BRISTOL-MYERS SQUIBB COMPANY Exhibit 99.1 1 Bristol Myers Squibb: Built for Growth 44th Annual J.P. Morgan Healthcare Conference Christopher Boerner, Ph. D., Board Chair & CEO January 12th, 2026 Forward Looking Statements 2 This presentation (as well as the oral statements made with respect to the information contained in this presentation) contains statements about Bristol-Myers Squibb Company’s (the “Company”) future financial resu…
Read attachment ↗